ORC ID ">
  • Users Online: 4591
  • Home
  • Print this page
  • Email this page
RESEARCH ARTICLE
Year : 2021  |  Volume : 16  |  Issue : 2  |  Page : 345-349

Role of miR-132/methyl-CpG-binding protein 2 in the regulation of neural stem cell differentiation


Department of Orthopedics, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China

Correspondence Address:
Shao-Hua Li
Department of Orthopedics, Shanghai Tenth People's Hospital, Tongji University, Shanghai
China
Zhong Wu
Department of Orthopedics, Shanghai Tenth People's Hospital, Tongji University, Shanghai
China
Login to access the Email id

Source of Support: This study was supported by the National Natural Science Foundation of China, No. 81271990 (to SHL), Conflict of Interest: None


DOI: 10.4103/1673-5374.290908

Rights and Permissions

Methyl-CpG-binding protein 2 (MeCP2) is a well-known transcription repressor, and mutations in MECP2 cause serious neurological disorders. Many studies have suggested that MeCP2 is involved in neural maturation only, and have not reported its role in neural stem cell differentiation. In the present study, we investigated this possible role of MeCP2 in neural stem cells. We used two different differentiation methods to explore how MeCP2 influences neural stem cell differentiation. When we transfected MeCP2-overexpressing lentivirus into neural stem cells, astrocytic differentiation was impaired. This impaired astrocytic differentiation occurred even in conditions of 20% fetal bovine serum, which favored astrocytic differentiation. In addition, miR-132 had the largest expression change after differentiation among several central nervous system related miRNAs. A luciferase assay confirmed that miR-132 directly targeted MeCP2, and that miR-132 was able to reduce MeCP2 expression at both the RNA and protein levels. The upregulation of miR-132 by miRNA mimics promoted astrocytic differentiation, which was fully recovered by MeCP2 overexpression. These results indicate that miR-132 regulates cell lineage differentiation by reducing MeCP2. The study was approved by the Ethics Committee of Shanghai Tenth People's Hospital of TongJi University, China (approval No. SHDSYY-2018-4748) on March 10, 2018.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed241    
    Printed0    
    Emailed0    
    PDF Downloaded75    
    Comments [Add]    

Recommend this journal